The European dental biomaterial market will grow moderately through 2027, driven by an increasing number of GDs offering dental implant therapy and widespread awareness of dental implant…
The European dental biomaterial market will grow moderately through 2027, driven by an increasing number of GDs offering dental implant therapy and widespread awareness of dental implant…
The North American dental biomaterial market will undergo moderate growth through 2027, largely driven by the rising popularity of dental implant treatments, many cases of which involve the use…
The European drug delivery device market will see modest growth through 2027. Although the increasing availability of biosimilars will negatively impact ASPs, the greater affordability of lower-…